repaglinide (Hasegawa Co Ltd)
90
Structured Review
Hasegawa Co Ltd
repaglinide
Repaglinide, supplied by Hasegawa Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/repaglinide/repaglinide/pm40435179-288-16-2
Average 90 stars, based on 1 article reviews
Repaglinide, supplied by Hasegawa Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/repaglinide/repaglinide/pm40435179-288-16-2
Average 90 stars, based on 1 article reviews
repaglinide - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Long-term glycemic variability and the risk of cardiovascular diseases in type 2 diabetic patients: Effect of hypothetical interventions using parametric g-formula in a population-based historical cohort study. Article Snippet: Yamazaki M, Article Title: Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control. Article Snippet: Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control A.J.. Scheen a,∗, N. Esser b, N. Paquot b a Clinical Pharmacology Unit, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège and Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU de Liège, CHU Sart Tilman (B35), 4000 Liège 1, Belgium b Diabetology and Nutrition Unit, GIGA-I3, University of Liege, and Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU de Liège, Liège, Belgium Article Title: Effects of vildagliptin versus saxagliptin on daily acute glucose fluctuations in Chinese patients with T2DM inadequately controlled with a combination of metformin and sulfonylurea. Article Snippet: Objective: The present study aimed to compare the effects of dipeptidylpeptidase-4 (DPP-4) inhibitors vildagliptin and saxagliptin on 24-hour acute glucose fluctuations in Chinese patients with type 2 diabetes mellitus (T2DM) inadequately controlled with a combination of metformin and sulfonylurea.. Research design and methods: This was a 24-week, prospective, randomized, open-label, activecontrolled study.. Patients (N=73) with T2DM who had inadequate glycemic control (HbA1c 7.0%–10.0%) with a stable dosage of metformin plus gliclazide for more than 3 months were randomized to receive either vildagliptin 50 mg twice daily (BID, n=37) or saxagliptin 5 mg once daily (QD, n=36). |